|
1
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baguley BC: Multidrug resistance in
cancer. Methods Mol Biol. 596:1–14. 2010. View Article : Google Scholar
|
|
3
|
Haimeur A, Conseil G, Deeley RG and Cole
SP: The MRP-related and BCRP/ABCG2 multidrug resistance proteins:
Biology, substrate specificity and regulation. Curr Drug Metab.
5:21–53. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Redmond KM, Wilson TR, Johnston PG and
Longley DB: Resistance mechanisms to cancer chemotherapy. Front
Biosci. 13:5138–5154. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Szakács G, Annereau JP, Lababidi S,
Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD,
Reimers M, et al: Predicting drug sensitivity and resistance:
Profiling ABC transporter genes in cancer cells. Cancer Cell.
6:129–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deeley RG and Cole SP: Substrate
recognition and transport by multidrug resistance protein 1
(ABCC1). FEBS Lett. 580:1103–1111. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Litman T, Druley TE, Stein WD and Bates
SE: From MDR to MXR: New understanding of multidrug resistance
systems, their properties and clinical significance. Cell Mol Life
Sci. 58:931–959. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baguley BC: Multiple drug resistance
mechanisms in cancer. Mol Biotechnol. 46:308–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang A, Au WY and Kwong YL: Caveolin-1
gene is coordinately regulated with the multidrug resistance 1 gene
in normal and leukemic bone marrow. Leuk Res. 28:973–977. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim KJ, Moon SM, Kim SA, Kang KW, Yoon JH
and Ahn SG: Transcriptional regulation of MDR-1 by HOXC6 in
multidrug-resistant cells. Oncogene. 32:3339–3349. 2013. View Article : Google Scholar
|
|
11
|
Chen J, Keltner L, Christophersen J, Zheng
F, Krouse M, Singhal A and Wang SS: New technology for deep light
distribution in tissue for phototherapy. Cancer J. 8:154–163. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dolmans DE, Fukumura D and Jain RK:
Photodynamic therapy for cancer. Nat Rev Cancer. 3:380–387. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kessel D and Erickson C: Porphyrin
photosensitization of multi-drug resistant cell types. Photochem
Photobiol. 55:397–399. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu HL, Syu WJ, Nishiyama N, Kataoka K and
Lai PS: Dendrimer phthalocyanine-encapsulated polymeric
micelle-mediated photochemical internalization extends the efficacy
of photodynamic therapy and overcomes drug-resistance in vivo. J
Control Release. 155:458–464. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gulati SC, Lemoli RM, Igarashi T and
Atzpodien J: Newer options for treating drug-resistant (MDR+)
cancer cells using photoradiation therapy. Leuk Lymphoma.
12:427–433. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoon HE, Oh SH, Kim SA, Yoon JH and Ahn
SG: Pheophorbide a-mediated photodynamic therapy induces autophagy
and apoptosis via the activation of MAPKs in human skin cancer
cells. Oncol Rep. 31:137–144. 2014.
|
|
17
|
Ahn MY, Yoon HE, Kwon SM, Lee J, Min SK,
Kim YC, Ahn SG and Yoon JH: Synthesized pheophorbide a-mediated
photo-dynamic therapy induced apoptosis and autophagy in human oral
squamous carcinoma cells. J Oral Pathol Med. 42:17–25. 2013.
View Article : Google Scholar
|
|
18
|
Ahn MY, Kwon SM, Kim YC, Ahn SG and Yoon
JH: Pheophorbide a-mediated photodynamic therapy induces apoptotic
cell death in murine oral squamous cell carcinoma in vitro and in
vivo. Oncol Rep. 27:1772–1778. 2012.PubMed/NCBI
|
|
19
|
Tang PM, Chan JY, Au SW, Kong SK, Tsui SK,
Waye MM, Mak TC, Fong WP and Fung KP: Pheophorbide a, an active
compound isolated from Scutellaria barbata, possesses photodynamic
activities by inducing apoptosis in human hepatocellular carcinoma.
Cancer Biol Ther. 5:1111–1116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang PM, Zhang DM, Xuan NH, Tsui SK, Waye
MM, Kong SK, Fong WP and Fung KP: Photodynamic therapy inhibits
P-glycoprotein mediated multidrug resistance via JNK activation in
human hepatocellular carcinoma using the photosensitizer
pheophorbide a. Mol Cancer. 8:56–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hajri A, Wack S, Meyer C, Smith MK,
Leberquier C, Kedinger M and Aprahamian M: In vitro and in vivo
efficacy of photofrin and pheophorbide a, a bacteriochlorin, in
photodynamic therapy of colonic cancer cells. Photochem Photobiol.
75:140–148. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin ZH, Miyoshi N, Ishiguro K, Umemura S,
Kawabata K, Yumita N, Sakata I, Takaoka K, Udagawa T, Nakajima S,
et al: Combination effect of photodynamic and sonodynamic therapy
on experimental skin squamous cell carcinoma in C3H/HeN mice. J
Dermatol. 27:294–306. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bui-Xuan NH, Tang PM, Wong CK and Fung KP:
Photo-activated pheophorbide-a, an active component of Scutellaria
barbata, enhances apoptosis via the suppression of ERK-mediated
autophagy in the estrogen receptor-negative human breast
adeno-carcinoma cells MDA-MB-231. J Ethnopharmacol. 131:95–103.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bodey B, Bodey B Jr, Siegel SE and Kaiser
HE: Immunocytochemical detection of the homeobox B3, B4, and C6
gene products in breast carcinomas. Anticancer Res. 20(5A):
3281–3286. 2000.PubMed/NCBI
|
|
25
|
Castronovo V, Kusaka M, Chariot A, Gielen
J and Sobel M: Homeobox genes: Potential candidates for the
transcriptional control of the transformed and invasive phenotype.
Biochem Pharmacol. 47:137–143. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fujiki K, Duerr EM, Kikuchi H, Ng A,
Xavier RJ, Mizukami Y, Imamura T, Kulke MH and Chung DC: Hoxc6 is
overexpressed in gastrointestinal carcinoids and interacts with
JunD to regulate tumor growth. Gastroenterology. 135:907–916.
916.e1–916.e2. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bodey B, Bodey B Jr, Siegel SE, Luck JV
and Kaiser HE: Homeobox B3, B4, and C6 gene product expression in
osteo-sarcomas as detected by immunocytochemistry. Anticancer Res.
20:2717–2721. 2000.PubMed/NCBI
|
|
28
|
Miller GJ, Miller HL, van Bokhoven A,
Lambert JR, Werahera PN, Schirripa O, Lucia MS and Nordeen SK:
Aberrant HOXC expression accompanies the malignant phenotype in
human prostate. Cancer Res. 63:5879–5888. 2003.PubMed/NCBI
|
|
29
|
McCabe CD, Spyropoulos DD, Martin D and
Moreno CS: Genome-wide analysis of the homeobox C6 transcriptional
network in prostate cancer. Cancer Res. 68:1988–1996. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grishina IB, Kim SY, Ferrara C,
Makarenkova HP and Walden PD: BMP7 inhibits branching morphogenesis
in the prostate gland and interferes with Notch signaling. Dev
Biol. 288:334–347. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ricort JM and Binoux M: Insulin-like
growth factor-binding protein-3 activates a phosphotyrosine
phosphatase. Effects on the insulin-like growth factor signaling
pathway. J Biol Chem. 277:19448–19454. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
van der Geer P, Hunter T and Lindberg RA:
Receptor protein-tyrosine kinases and their signal transduction
pathways. Annu Rev Cell Biol. 10:251–337. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin Y, Liu G, Zhang Y, Hu YP, Yu K, Lin C,
McKeehan K, Xuan JW, Ornitz DM, Shen MM, et al: Fibroblast growth
factor receptor 2 tyrosine kinase is required for prostatic
morphogenesis and the acquisition of strict androgen dependency for
adult tissue homeostasis. Development. 134:723–734. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moon SM, Kim SA, Yoon JH and Ahn SG: HOXC6
is deregulated in human head and neck squamous cell carcinoma and
modulates Bcl-2 expression. J Biol Chem. 287:35678–35688. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cho S, Lu M, He X, Ee PL, Bhat U,
Schneider E, Miele L and Beck WT: Notch1 regulates the expression
of the multidrug resistance gene ABCC1/MRP1 in cultured cancer
cells. Proc Natl Acad Sci USA. 108:20778–20783. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chiu LY, Hu ME, Yang TY, Hsin IL, Ko JL,
Tsai KJ and Sheu GT: Immunomodulatory protein from ganoderma
microsporum induces pro-death autophagy through Akt-mTOR-p70S6K
pathway inhibition in multidrug resistant lung cancer cells. PLoS
One. 10:e01257742015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Galoian K, Temple HT and Galoyan A: mTORC1
inhibition and ECM-cell adhesion-independent drug resistance via
PI3K-AKT and PI3K-RAS-MAPK feedback loops. Tumour Biol. 33:885–890.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ye S, Shen J, Choy E, Yang C, Mankin H,
Hornicek F and Duan Z: p53 overexpression increases
chemosensitivity in multidrug-resistant osteosarcoma cell lines.
Cancer Chemother Pharmacol. 77:349–356. 2016. View Article : Google Scholar
|
|
39
|
Yajima T, Ochiai H, Uchiyama T, Takano N,
Shibahara T and Azuma T: Resistance to cytotoxic
chemotherapy-induced apoptosis in side population cells of human
oral squamous cell carcinoma cell line Ho-1-N-1. Int J Oncol.
35:273–280. 2009.PubMed/NCBI
|
|
40
|
Yan S, Ma D, Ji M, Guo D, Dai J, Zhao P
and Ji C: Expression profile of Notch-related genes in multidrug
resistant K562/A02 cells compared with parental K562 cells. Int J
Lab Hematol. 32:150–158. 2010. View Article : Google Scholar
|
|
41
|
Zhou H, Tang Y, Liang X, Yang X, Yang J,
Zhu G, Zheng M and Zhang C: RNAi targeting urokinase-type
plasminogen activator receptor inhibits metastasis and progression
of oral squamous cell carcinoma in vivo. Int J Cancer. 125:453–462.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang JM, Xu Z, Wu H, Zhu H, Wu X and Hait
WN: Overexpression of extracellular matrix metalloproteinase
inducer in multidrug resistant cancer cells. Mol Cancer Res.
1:420–427. 2003.PubMed/NCBI
|
|
43
|
Liu QH, Shi ML, Sun C, Bai J and Zheng JN:
Role of the ERK1/2 pathway in tumor chemoresistance and tumor
therapy. Bioorg Med Chem Lett. 25:192–197. 2015. View Article : Google Scholar
|
